Highbridge Capital Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-40,342
Closed -$3.97M 453
2018
Q3
$3.97M Buy
+40,342
New +$3.73M 0.09% 239
2017
Q4
Sell
-26,017
Closed -$2.08M 1833
2017
Q3
$2.02M Buy
26,017
+21,186
+439% +$1.76M 0.03% 436
2017
Q2
$429K Sell
4,831
-4,013
-45% -$338K 0.01% 804
2017
Q1
$713K Sell
8,844
-395,240
-98% -$30.9M 0.01% 750
2016
Q4
$28.8M Buy
+404,084
New +$31.7M 0.51% 45
2016
Q2
Sell
-146,978
Closed -$11.9M 1605
2016
Q1
$11M Buy
+146,978
New +$11.1M 0.18% 154
2015
Q4
Sell
-9,271
Closed -$698K 1673
2015
Q3
$621K Buy
9,271
+6,318
+214% +$465K 0.01% 954
2015
Q2
$219K Buy
+2,953
New +$226K ﹤0.01% 1259
2015
Q1
Sell
-3,000
Closed -$227K 1510
2014
Q4
$217K Buy
+3,000
New +$208K ﹤0.01% 1042
2014
Q3
Sell
-334,740
Closed -$21.3M 1290
2014
Q2
$21.3M Sell
334,740
-530,410
-61% -$32.2M 0.26% 101
2014
Q1
$53.2M Sell
865,150
-6,807
-0.8% -$397K 0.67% 35
2013
Q4
$50M Buy
871,957
+152,545
+21% +$8.65M 0.6% 35
2013
Q3
$38.3M Sell
719,412
-7,285
-1% -$392K 0.4% 57
2013
Q2
$37.4M Buy
+726,697
New +$35.9M 0.37% 56

Other funds holding MDT

Highbridge Capital Management's MDT Position: Q4 2018 in Review

Highbridge Capital Management sold out of Medtronic (MDT) in Q4 2018, closing a stake of 40,342 shares — an estimated $3.97M sold.

Highbridge Capital Management first reported a position in MDT in Q2 2013 and held it in 14 quarters. The position peaked at $53.2M in Q1 2014. 1,563 funds tracked by Wall St. Rank hold MDT as of Q4 2018.

  • Highbridge Capital Management reported no remaining Medtronic position as of Q4 2018 after selling out during the quarter.
  • Highbridge Capital Management sold 40,342 Medtronic shares in Q4 2018, an estimated $3.97M.
  • Highbridge Capital Management first reported a position in Medtronic in Q2 2013 and held it in 14 quarters.
  • Highbridge Capital Management's Medtronic position peaked at $53.2M in Q1 2014.
  • 1,563 funds tracked by Wall St. Rank held Medtronic as of Q4 2018.

Based on Highbridge Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.